IMVT
Immunovant, Inc.
$39.71
-1.38 (-3.36%)
At close · Jul 10
Market Cap
$8.15B
Shares
205,308,917
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-20 | — | |
| 10-K | 2026-05-20 | 2026-03-31 | |
| 8-K | 2026-02-06 | — | |
| 10-Q | 2026-02-06 | 2025-12-31 | |
| 8-K | 2025-12-12 | 2025-12-10 | |
| 8-K | 2025-12-11 | 2025-12-10 | |
| 8-K | 2025-11-21 | — | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-09-03 | — | |
| 8-K | 2025-08-28 | 2025-08-27 | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-07-29 | 2025-07-28 | |
| DEF 14A | 2025-07-09 | 2025-08-27 | |
| 8-K | 2025-05-29 | — | |
| 10-K | 2025-05-29 | 2025-03-31 | |
| 8-K | 2025-04-21 | 2025-04-18 | |
| 8-K | 2025-03-19 | — | |
| 10-Q | 2025-02-06 | 2024-12-31 | |
| 8-K | 2025-02-06 | — | |
| 8-K | 2025-01-24 | — | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-09-09 | — | |
| 8-K | 2024-08-13 | 2024-08-12 | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| DEF 14A | 2024-06-26 | 2024-08-12 | |
| 8-K | 2024-05-29 | — | |
| 10-K | 2024-05-29 | 2024-03-31 | |
| 8-K | 2024-02-12 | — | |
| 10-Q | 2024-02-12 | 2023-12-31 | |
| 8-K | 2024-01-09 | — | |
| 8-K | 2023-12-20 | — | |
| 8-K | 2023-11-28 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-09-28 | 2023-09-26 | |
| 8-K | 2023-09-26 | — | |
| 8-K | 2023-08-23 | 2023-08-21 | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| 8-K | 2023-08-10 | — | |
| DEF 14A | 2023-06-26 | 2023-08-21 | |
| 10-K | 2023-05-22 | 2023-03-31 | |
| 8-K | 2023-05-22 | — | |
| 8-K | 2023-03-27 | — | |
| 8-K | 2023-02-03 | — |
Showing 1–50 of 101 filings